Immunoglobulin F(ab')2 fragment (Yuxi Jiuzhou Biotechnology)
马破伤风免疫球蛋白(F(ab’)2)（玉溪九洲）
Report date: 2023/12/26 14:24:21
Base Information
Drug NameImmunoglobulin F(ab')2 fragment (Yuxi Jiuzhou Biotechnology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2023/12/19
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesYuxi Jiuzhou Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesYuxi Jiuzhou Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A